• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

ASTMH 2010

3-7 November 2010

Atlanta, USA

The Drugs for Neglected Diseases initiative (DNDi) will participate in several activities at ASTMH 2010, including a joint symposium with Central Drug Research Institute (CDRI)on Visheral Leishmaniasis (VL) in the Indian Continent, a second symposium on VL in East Africa, a satellite symposium on Challenges and Successes of the FACT Project through Innovative Partnerships for the development of Artesunate Combination Therapies for Malaria, as well as several oral presentations.

Symposia

•    Friday, November 05, 2010 (1:30pm—3:15pm)

Title: Current Challenges and Opportunities in managing Visceral Leishmaniasis in the Indian subcontinent

Jointly organized by Drugs for Neglected Diseases initiative (DNDi) & Central Drug Research Institute (CDRI)

Chair: Prof. Kwang Poo Chang, Rosalind Franklin University of Medicine and Science, USA
Co-chair: Prof. Farrokh Modabber; Drugs for Neglected Diseases initiative (DNDi), Switzerland

Speakers:
puce Profs Kwang Poo Chang & Farrokh Modabber: Opening Remarks
puce Prof. Shyam Sundar (Banaras Hindu University, India): General Introduction and Current Clinical Management of VL in the Indian subcontinent
puce Prof Farrokh Modabber (DNDi, Switzerland): Potential new treatment options for VL: Combination therapy with liposomal amphotericin B, miltefosine and paromomycin
puce Dr. Larry Ming C. Chow (Hong Kong Polytechnic University Hong Kong): Strategies of reversing drug-resistance by using flavinoid dimmers
puce Prof. K.P. Chang (Chicago Medical School/RFUMS, USA): Therapeutic/prophylactic strategies with minimal risks of eliciting drug-resistance – Photomedicine
puce Dr. Neeloo Singh (Central Drug Research Institute, India): Analysis of drug resistance in clinical isolates
puce Panel members: Profs Jorger Alvar, Piero Olliaro: Panel discussion and question and answers

•   Saturday, November 06, 2010 (1:30pm—3:15pm)

Title: VL in East Africa- Current Needs and Latest Clinical Developments

Jointly organized by Drugs for Neglected Diseases initiative (DNDi) &  Leishmania East Africa Platform (LEAP)

Chair: Prof. Ahmed El Hassan, University of Khartoum, Sudan
Co-chair: Prof. Joseph Olobo, Makerere University, Kampala, Uganda

Speakers:
puce Dr. Monique Wasunna (Kenya Medical Research Institute, KEMRI): Leishmania East Africa Platform: a model for a clinical research platform in Africa
puce Dr. Manica Balasegaram (DNDi): Economic analysis of visceral leishmaniasis control in Sudan
puce Prof. Asrat Hailu (Addis Ababa University, Ethiopia): Ambisome: The experience in East Africa 
puce Dr. Ahmed Mudawi Musa (University of Khartoum, Sudan): A multicentre comparative trial of efficacy and safety of sodium stibogluconate (SSG), paromomycin (PM) and the combination of SSG and pM as first-line treatment for visceral leishmaniasis in East Africa

Satellite Symposium

•    Friday, November 05, 2010 (7:15pm—9:00pm)

Title: Challenges and Successes of the FACT Project through Innovative Partnerships for the Development of Artesunate Combination Therapies for Malaria

Chair: Chair: Prof. Nicholas White (Wellcome Trust Mahidol University, Bangkok, Thailand)
Co-chair: Dr. Piero Olliaro (WHO/TDR, Geneva, Switzerland)

Speakers:
puce Dr. Jean-René Kiechel (DNDi): Partnerships: The Way to Successful Antimalarial Development
puce Dr. Francois Bompart (sanofi-aventis, Paris, France): Public-Private Partnerships for ACT Development and Field Implementation
puce Dr. Ana Carolina Santelli (Brasilian Malaria Control Programme, Brazil): Implementation of ASMQ – Brazilian experience
puce Dr. Neena Valecha (National Institute of Malaria Research, New Delhi, India): Partnership in India and Beyond
puce Dr. Bernard Pécoul (DNDi): What Next? The Future of Partnerships

Booth

DNDi’s booth is #408. Please visit our team there to receive information about DNDi’s activities.

Other events

Loading...
20 May 2025

Geneva, Switzerland

Strengthening the global ecosystem for paediatric medicines: leadership, collaboration, and impact

21 May 2025

Geneva, Switzerland

Scaling impact: Climate & health solutions that drive change

7-10 May 2025

Amsterdam, The Netherlands

EASL Congress 2025

20-25 May 2025

Iguaçu Falls, Brazil

22nd ISHAM Congress

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License